It has been shown that the pan-AMPK activator 991 efficiently activates AMPK in isolated mouse skeletal muscle and elicits metabolic effects appropriate for treating T2D by stimulating glucose uptake and fatty acid oxidation (160, 471). Here, PRKAB1 is linked to type 2 diabetes mellitus.